Inspire Medical Systems, Inc. Company Analysis & Research
Inspire Medical Systems is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. The company offers the Inspire system, a neurostimulation technology that provides safe and effective treatment for moderate to severe OSA through a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The Inspire therapy represents a significant departure from traditional treatments like the cumbersome and often uncomfortable Continuous Positive Airway Pressure (CPAP) machines. The company markets its implantable device primarily through a network of sleep centers and hospitals with a business model that combines device sales with a supportive service infrastructure, with revenue streams fueled by initial device sales plus ongoing follow-ups and software updates.
Company Overview
Founded: 2007. Headquarters: Golden Valley, Minnesota, United States. Revenue: $912M. Ticker: INSP (NASDAQ).
Industry
Medical Devices - Sleep Medicine
Cyborg Score: 7/10 — Strong
Market-leading medical device company with FDA-approved sleep apnea treatment showing strong revenue growth, though facing near-term regulatory and litigation headwinds.
Inspire Medical reported fourth quarter revenue of $269 million (up 12%) and full year revenue of $912 million (up 14%), driven by growth at existing and new centers. The company maintains market leadership in sleep apnea neurostimulation with FDA-approved technology and strong demand. However, recent securities class action lawsuits and regulatory challenges like prior authorization programs may present headwinds.
Key Strategic Insights for Inspire Medical Systems, Inc.
- Full year 2025 revenue reached $912 million with 14% growth driven by expansion at existing and new centers
- Over 90% of centers now implanting Inspire V, the newest generation device
- WISeR Medicare prior authorization program impacting procedures in six states in Q1 2026
- Company originated as spinoff from Medtronic in 2007, providing strong pedigree and technology foundation
Recent Developments
- (December 2025) Multiple securities class action lawsuits filed following stock decline
- (2025) FDA approval for Inspire IV with 3 Tesla MRI compatibility
- (2025) Full year revenue of $912M with 14% YoY growth
- (Early 2026) WISeR Medicare prior authorization program implementation impacting procedures
Competitors & Competitive Landscape
- Various (ResMed, Philips) — Traditional air pressure devices for sleep apnea
- Various manufacturers — Mandibular advancement devices for OSA treatment
- Various providers — Surgical interventions for airway obstruction
Inspire competes with oral appliances and other surgical treatments that have greater penetration in the OSA treatment market and are better known to ENT physicians and sleep centers. Primary competitors include CPAP manufacturers and traditional surgical approaches, though Inspire's neurostimulation technology offers a differentiated solution for moderate to severe OSA patients seeking alternatives to continuous positive airway pressure therapy.
More Company Research
Asure Software, Inc. Interloop Limited South Plains Financial, Inc. CureVac N.V. secunet Security Networks AG Seadrill Limited Community Financial System, Inc. DiaSorin S.p.A. Synovus Financial Corp. Marico Limited Somnigroup International Inc. CMOC Group Limited bioAffinity Technologies, Inc. MoneyHero Limited Hooker Furnishings CorporationFull Company Research Reports
Looking for a more in-depth analysis of Inspire Medical Systems, Inc.? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, analyst debate audio, and saved-company audio playlists.